Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Stephanie BockGünther Weindl

Abstract

Langerhans cells (LCs) represent a highly specialized subset of epidermal dendritic cells (DCs), yet not fully understood in their function of balancing skin immunity. Here, we investigated in vitro generated Langerhans-like cells obtained from the human acute myeloid leukaemia cell line MUTZ-3 (MUTZ-LCs) to study TLR- and cytokine-dependent activation of epidermal DCs. MUTZ-LCs revealed high TLR2 expression and responded robustly to TLR2 engagement, confirmed by increased CD83, CD86, PD-L1 and IDO expression, upregulated IL-6, IL-12p40 and IL-23p19 mRNA levels IL-8 release. TLR2 activation reduced CCR6 and elevated CCR7 mRNA expression and induced migration of MUTZ-LCs towards CCL21. Similar results were obtained by stimulation with pro-inflammatory cytokines TNF-α and IL-1β whereas ligands of TLR3 and TLR4 failed to induce a fully mature phenotype. Despite limited cytokine gene expression and production for TLR2-activated MUTZ-LCs, co-culture with naive CD4(+) T cells led to significantly increased IFN-γ and IL-22 levels indicating Th1 differentiation independent of IL-12. TLR2-mediated effects were blocked by the putative TLR2/1 antagonist CU-CPT22, however, no selectivity for either TLR2/1 or TLR2/6 was observed. Computer-a...Continue Reading

References

Jun 3, 2000·Annual Review of Immunology·J BanchereauK Palucka
Mar 27, 2002·Nature Reviews. Immunology·Ken Shortman, Yong-Jun Liu
Aug 30, 2002·Trends in Immunology·Manfred B Lutz, Gerold Schuler
Aug 12, 2003·Proteins·Marcel L VerdonkRichard D Taylor
Jan 26, 2005·Journal of Chemical Information and Modeling·Gerhard Wolber, Thierry Langer
Feb 3, 2005·Medical Mycology·Alexander RoederHans Christian Korting
Feb 28, 2007·Infection and Immunity·Melinda J EkkensEdward J Pearce
Nov 10, 2007·The Journal of Clinical Investigation·Günther WeindlMartin Schaller
Jun 5, 2008·Cancer Immunology, Immunotherapy : CII·Tanja D de GruijlRik J Scheper
Jul 31, 2008·Journal of Leukocyte Biology·Saskia J A M SantegoetsTanja D de Gruijl
Oct 17, 2008·European Journal of Immunology·Krista OuwehandSusan Gibbs
Nov 26, 2008·Nature Reviews. Immunology·Miriam MeradMatthew Collin
Apr 8, 2009·European Journal of Immunology·Ehsan AliahmadiMatthias Peiser
Nov 3, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Krista OuwehandSusan Gibbs
Nov 19, 2009·The Journal of Clinical Investigation·Stefanie EyerichAndrea Cavani
Dec 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hideki FujitaJames G Krueger
Jan 1, 2010·Journal of Leukocyte Biology·Marein A W P de JongTeunis B H Geijtenbeek
Mar 3, 2010·Immunological Reviews·Nikolaus RomaniPatrizia Stoitzner
Aug 18, 2010·Vaccine·Folkert SteinhagenDennis M Klinman
Feb 8, 2013·The Journal of Investigative Dermatology·Angelic M G van der AarEsther C de Jong
Apr 30, 2013·Immunology·Matthew CollinMuzlifah Haniffa
Apr 30, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Manuel HitzlerMatthias Peiser
Jun 15, 2013·Leukemia·Y WeiG Garcia-Manero
Jul 16, 2013·International Journal of Cancer. Journal International Du Cancer·Ke LiZhuo-Wei Hu
May 3, 2014·International Journal of Cancer. Journal International Du Cancer·Takashi AkazawaNorimitsu Inoue
Aug 1, 2015·Journal of Immunology Research·André Said, Günther Weindl
Sep 29, 2015·Integrative Biology : Quantitative Biosciences From Nano to Macro·Lewis E ScottChristopher A Lemmon

❮ Previous
Next ❯

Citations

Mar 28, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Wu-Ching UenCheng-Jeng Tai
May 22, 2018·Frontiers in Pharmacology·Ian F Caplan, Kathleen A Maguire-Zeiss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.